High Tide Celebrates New Developments in Cannabis Regulations
The Company is actively evaluating licensing pathways for its Canna Cabana retail brand, a strategic move that reflects the shifting landscape in cannabis policy.
Amid ongoing discussions about cannabis legislation, High Tide Inc. (Nasdaq: HITI) embraces a significant announcement from the White House. This Executive Order marks an important step toward the rescheduling of cannabis. Furthermore, the Centers for Medicare & Medicaid Services is expected to initiate a pilot program allowing certain Medicare beneficiaries to receive CBD treatments at no cost.
Raj Grover, the Founder and CEO of High Tide, described this Executive Order as one of the most crucial advancements in U.S. cannabis reform in over half a century. While the rescheduling doesn’t entail full legalization, it does represent a shift toward recognizing the need for sensible cannabis policies. The conversations around reimbursement for CBD treatments highlight a growing bipartisan momentum that could reshape the future of cannabis in America.
High Tide has mastered a unique retail model that can thrive in various jurisdictions, putting it in an excellent position to capitalize on upcoming opportunities, especially in the hemp-derived CBD market. With established brands like NuLeaf Naturals and FAB CBD, the Company is preparing product lines aligned with Medicare standards, aiming for inclusion in Medicare Advantage supplemental benefits.
As the Company moves forward, they are exploring ways to expand Canna Cabana into the U.S. market through licensing. This strategy aims to align with the evolving regulatory environment while ensuring compliance with existing NASDAQ and TSXV requirements. High Tide boasts a significant database of roughly four million U.S. customers, positioning them for substantial long-term growth in both the federally compliant CBD wellness sector and the regulated cannabis market.
In anticipation of the forthcoming changes, High Tide has begun to assess the viability of extending its flagship retail brand, Canna Cabana, into the United States via a licensing framework. This evaluation coincides with the positioning of their hemp-derived CBD products, particularly NuLeaf Naturals and FAB CBD, which are set to benefit from potential Medicare inclusion due to their TH-free and broad-spectrum options, compliant with Medicare's requirements.
High Tide is thrilled to announce a renewed partnership with the IR Agency. Starting from December 19, they will provide investor relations services, enhancing communication with investors and stakeholders alike. This agreement, which spans up to one year, involves sharing critical Company information and building a digital community focused on cannabis advancements. The Agency will be compensated at a rate of USD$140,000 per month for their services, adhering to compliance with TSX Venture Exchange guidelines.
About High Tide Inc.
High Tide Inc. is recognized as a community-driven, retail-focused cannabis enterprise that aims to unlock the full potential of cannabis. Its wholly owned subsidiary, Canna Cabana, ranks as the second-largest cannabis retail brand globally. High Tide (HITI) operates entirely with the cannabis consumer in mind, utilizing a fully integrated approach that covers various aspects, including:
Retail: Canna Cabana™ leads as Canada’s largest cannabis retailer, with over 218 locations across the country and one in Germany. Additionally, High Tide has taken the initiative in e-commerce, providing accessories and hemp-derived CBD products through various platforms.
Medical Cannabis Distribution: The Company’s division, Remexian Pharma GmbH, stands as a leading German pharmaceutical entity focused on the importation and wholesale of medical cannabis, bringing valuable products to the market while adhering to regulations.
High Tide’s continued innovation has earned it accolades, including recognition as one of Canada’s Top Growing Companies by the Globe and Mail and a top rank on FT’s list of Fastest Growing Companies in the Americas.
To learn more about High Tide, explore their website for insights into the latest developments and their unwavering commitment to enhancing the cannabis experience.
Contact Information
For media inquiries, reach out to Carter Brownlee, Communications Advisor at High Tide Inc., or Vahan Ajamian for investor relations queries. Contact details can be found on the Company’s website, ensuring a direct line of communication for all stakeholders.
Frequently Asked Questions
What recent changes did High Tide welcome?
High Tide welcomed the Executive Order from the White House regarding cannabis rescheduling and Medicare reimbursements for CBD products.
How does the Executive Order affect High Tide?
The Executive Order supports High Tide's strategic initiatives to expand its market presence, particularly in the U.S. with its Canna Cabana brand.
What products are NuLeaf Naturals and FAB CBD developing?
NuLeaf Naturals and FAB CBD are creating products aligned with Medicare standards for potential inclusion in supplemental benefits.
What is the significance of the renewed partnership with the IR Agency?
The renewed partnership enhances investor communications and engagement, providing valuable information to shareholders and the financial community.
What is High Tide's mission?
High Tide aims to leverage the strength of cannabis, offering a diverse range of products while promoting responsible and innovative cannabis consumption.
